Atypical cells in urine - Validation of a new tumormarker in urothelial carcinoma (AG ACU)

Atypical cells in urine - Validation of a new tumormarker in urothelial carcinoma (AG ACU) - AG ACU

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036049

Enrollment

200

Registered

2025-02-04

Start date

2022-08-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C68

Interventions

Group 1: urine from patients with urothelial carcinoma Group 2: urine from patients without oruthelial carncinoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Capable of giving consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Atypical cells are significant different to control group	—

Secondary

Measure	Time frame
Atypical cells are significant different to urin cytology Atypical cells are significant different to each tumor stage	—

Countries

Germany

Contacts

Public ContactMaximilian Reimann

Charité

maximilian.reimann@charite.de+4930450615249

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026